Lupus Research Alliance | Lupus Ventures
◆ Investment Thesis
Mission-driven investment model blending venture capital with philanthropic flexibility to support promising treatment and diagnostic options for systemic lupus erythematosus (SLE) and related autoimmune conditions.
◆ About Lupus Research Alliance
Lupus Ventures is the venture investment fund of the Lupus Research Alliance, dedicated to advancing treatments and diagnostics for systemic lupus erythematosus (SLE), its manifestations, and related autoimmune conditions.[1][3] It bridges the gap between innovative science and commercial reality by providing financing to biotech companies that have exhausted non-dilutive funding but lack traction with traditional VCs, prioritizing 'return on mission' over pure financial returns.[2][3] The fund invests across all development stages (preclinical to commercial) and private financing rounds (NewCo to Series C+).[3]
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Nishant Rastogi | Managing Director of Lupus Ventures | Senior | |
| Albert T. Roy | President & CEO, Lupus Research Alliance | — | in |
◆ Tracked Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Lupus Ventures invest in?
Lupus Ventures invests in Biotech, Diagnostics, Drug Discovery, Digital Health and Medtech at the seed, series-a and series-b stages.
Which geographies does Lupus Ventures focus on?
Lupus Ventures focuses on Worldwide, and is headquartered in United States.
Which startups has Lupus Ventures backed?
Lupus Ventures has 3 tracked investments on Fusion42, including Vorflux, Daya and The New Era of Shopping.